{"id":"https://openalex.org/W2175253063","doi":"https://doi.org/10.1182/blood.v124.21.1708.1708","title":"Mature Follow up from a Phase 2 Study of PI3K-Delta Inhibitor Idelalisib in Patients with Double (Rituximab and Alkylating agent)-Refractory Indolent B-Cell Non-Hodgkin Lymphoma (iNHL)","display_name":"Mature Follow up from a Phase 2 Study of PI3K-Delta Inhibitor Idelalisib in Patients with Double (Rituximab and Alkylating agent)-Refractory Indolent B-Cell Non-Hodgkin Lymphoma (iNHL)","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2175253063","doi":"https://doi.org/10.1182/blood.v124.21.1708.1708","mag":"2175253063"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.1708.1708","doi":"https://doi.org/10.1182/blood.v124.21.1708.1708","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.1708.1708","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K. Gopal","raw_affiliation_strings":["University of Washington School of Medicine, Seattle, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington School of Medicine, Seattle, WA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069054551","display_name":"Brad S. Kahl","orcid":"https://orcid.org/0000-0003-0459-6609","observed_orcids":["https://orcid.org/0000-0003-0459-6609"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad S. Kahl","raw_affiliation_strings":["University of Wisconsin Carbone Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Wisconsin Carbone Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I135310074","https://openalex.org/I4210103341"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081213752","display_name":"Sven de Vos","orcid":"https://orcid.org/0000-0002-6715-4851","observed_orcids":["https://orcid.org/0000-0002-6715-4851"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210096972","display_name":"Los Angeles Medical Center","ror":"https://ror.org/00spys463","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343052199","https://openalex.org/I4210096972"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sven de Vos","raw_affiliation_strings":["University of California at Los Angeles Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California at Los Angeles Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210096972"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015361329","display_name":"Nina D. Wagner\u2010Johnston","orcid":"https://orcid.org/0000-0001-6529-9793","observed_orcids":["https://orcid.org/0000-0001-6529-9793"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nina D. Wagner-Johnston","raw_affiliation_strings":["Washington University School of Medicine, Saint Louis, MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, Saint Louis, MO","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080630441","display_name":"Stephen J. Schuster","orcid":"https://orcid.org/0000-0002-3376-8978","observed_orcids":["https://orcid.org/0000-0002-3376-8978"]},"institutions":[{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen J. Schuster","raw_affiliation_strings":["Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102788725","display_name":"Wojciech J. Jurczak","orcid":"https://orcid.org/0000-0003-1879-8084","observed_orcids":["https://orcid.org/0000-0003-1879-8084"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Wojciech Jurczak","raw_affiliation_strings":["Jagiellonian University, Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jagiellonian University, Krakow, Poland","institution_ids":["https://openalex.org/I126596746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000959540","display_name":"Ian W. Flinn","orcid":"https://orcid.org/0000-0001-6724-290X","observed_orcids":["https://orcid.org/0000-0001-6724-290X"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian W. Flinn","raw_affiliation_strings":["Sarah Cannon Cancer Institute, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Cancer Institute, Nashville, TN","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082892912","display_name":"Christopher R. Flowers","orcid":"https://orcid.org/0000-0002-9524-3990","observed_orcids":["https://orcid.org/0000-0002-9524-3990"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher R. Flowers","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040141808","display_name":"Peter Martin","orcid":"https://orcid.org/0000-0001-7813-1551","observed_orcids":["https://orcid.org/0000-0001-7813-1551"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Martin","raw_affiliation_strings":["Weill Cornell Medical College, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medical College, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067716137","display_name":"Andreas Viardot","orcid":"https://orcid.org/0000-0001-9593-6327","observed_orcids":["https://orcid.org/0000-0001-9593-6327"]},"institutions":[{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Viardot","raw_affiliation_strings":["University Hospital of Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056946123","display_name":"Kristie A. Blum","orcid":"https://orcid.org/0000-0001-7363-9794","observed_orcids":["https://orcid.org/0000-0001-7363-9794","https://orcid.org/0000-0003-4229-2569"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristie A. Blum","raw_affiliation_strings":["The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089882481","display_name":"Andre Henri Goy","orcid":"https://orcid.org/0000-0001-5125-6522","observed_orcids":["https://orcid.org/0000-0001-5125-6522"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andre Goy","raw_affiliation_strings":["The John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069477380","display_name":"Andrew John Davies","orcid":"https://orcid.org/0000-0002-7517-6938","observed_orcids":["https://orcid.org/0000-0002-7517-6938"]},"institutions":[{"id":"https://openalex.org/I43439940","display_name":"University of Southampton","ror":"https://ror.org/01ryk1543","country_code":"GB","type":"education","lineage":["https://openalex.org/I43439940"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Davies","raw_affiliation_strings":["Cancer Sciences Division, University of Southampton, Southampton, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Sciences Division, University of Southampton, Southampton, United Kingdom","institution_ids":["https://openalex.org/I43439940"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091882595","display_name":"Pier Luigi Zinzani","orcid":"https://orcid.org/0000-0002-2112-2651","observed_orcids":["https://orcid.org/0000-0002-2112-2651"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pier Luigi Zinzani","raw_affiliation_strings":["Institute of Hematology and Oncology, University of Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Hematology and Oncology, University of Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046049357","display_name":"Martin H. Dreyling","orcid":"https://orcid.org/0000-0002-0358-5249","observed_orcids":["https://orcid.org/0000-0002-0358-5249"]},"institutions":[{"id":"https://openalex.org/I4210121101","display_name":"M\u00fcnchen Klinik","ror":"https://ror.org/03pfshj32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210121101"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin H. Dreyling","raw_affiliation_strings":["University Hospital Grosshadern, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Grosshadern, Munich, Germany","institution_ids":["https://openalex.org/I4210121101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001765276","display_name":"Leanne M. Holes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leanne M. Holes","raw_affiliation_strings":["Gilead Sciences, Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085791499","display_name":"Bess E. Sorensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bess Sorensen","raw_affiliation_strings":["Gilead Sciences, Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027453053","display_name":"Wayne Russell Godfrey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne R. Godfrey","raw_affiliation_strings":["Gilead Sciences, Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences, Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086354986","display_name":"Gilles A. Salles","orcid":"https://orcid.org/0000-0002-9541-8666","observed_orcids":["https://orcid.org/0000-0002-9541-8666"]},"institutions":[{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Andre Salles","raw_affiliation_strings":["Centre Hospitalier Lyon-Sud, Pierre-Benite, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Lyon-Sud, Pierre-Benite, France","institution_ids":["https://openalex.org/I4210113288"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":20,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":4.6997,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.95551513,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"124","issue":"21","first_page":"1708","last_page":"1708"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9150000214576721,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.08259999752044678,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idelalisib","display_name":"idelalisib","score":0.996999979019165},{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.8870000243186951},{"id":"https://openalex.org/keywords/indolent-b-cell-non-hodgkin-lymphoma","display_name":"indolent B-cell non-Hodgkin lymphoma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.8130000233650208},{"id":"https://openalex.org/keywords/small-lymphocytic-lymphoma","display_name":"small lymphocytic lymphoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/marginal-zone-lymphoma","display_name":"marginal zone lymphoma","score":0.953000009059906},{"id":"https://openalex.org/keywords/lymphoplasmacytic-lymphoma","display_name":"lymphoplasmacytic lymphoma","score":0.9169999957084656},{"id":"https://openalex.org/keywords/waldenstrom-macroglobulinemia","display_name":"Waldenstr\u00f6m macroglobulinemia","score":0.9539999961853027},{"id":"https://openalex.org/keywords/bendamustine-plus-rituximab","display_name":"bendamustine-rituximab","score":0.7459999918937683},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.7409999966621399},{"id":"https://openalex.org/keywords/remission-duration","display_name":"remission duration","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C2779260929","wikidata":"https://www.wikidata.org/wiki/Q5908266","display_name":"Idelalisib","level":5,"score":0.8796831965446472},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8508373498916626},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7818055748939514},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6066839098930359},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6066797971725464},{"id":"https://openalex.org/C2910423619","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Lymphoplasmacytic Lymphoma","level":4,"score":0.5785181522369385},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5121309757232666},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4888719916343689},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.485563725233078},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.4681420922279358},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.4433598816394806},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4364233613014221},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3893916606903076},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36864739656448364},{"id":"https://openalex.org/C2781038049","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Waldenstrom macroglobulinemia","level":3,"score":0.3459523916244507},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.20774978399276733},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.17958253622055054},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.1708.1708","doi":"https://doi.org/10.1182/blood.v124.21.1708.1708","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.1708.1708","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4230754783","https://openalex.org/W2555231866","https://openalex.org/W2597467395","https://openalex.org/W1857647970","https://openalex.org/W2602086903","https://openalex.org/W2507938600","https://openalex.org/W4246430667","https://openalex.org/W2605618073","https://openalex.org/W4248902124","https://openalex.org/W2244500181"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Rituximab-alkylator":[2],"combinations":[3],"are":[4,30],"the":[5,203,341,471,626,655,702],"standard":[6,182],"therapies":[7,90,252],"for":[8,41,77,194,400,415,437,458,482,657,701,719],"patients":[9,81,502,705,718,740,758],"(pts)":[10],"with":[11,91,118,126,352,385,602,631,666,715],"iNHL,":[12],"however,":[13],"refractory":[14,129,289,299],"disease":[15,128,169,315,387,648],"nearly":[16],"uniformly":[17],"develops.":[18],"Once":[19],"iNHL":[20,69,115,122,401,416,438,600],"becomes":[21],"\u0093double-refractory\u0094":[22],"to":[23,33,130,290,300,321,339,365,376,466,572,651,729],"both":[24,131],"rituximab":[25,132,721],"+":[26],"alkylating":[27,135],"agents,":[28],"there":[29],"limited":[31],"options":[32],"induce":[34],"durable":[35],"remissions.":[36],"PI3K-delta":[37],"signaling":[38],"is":[39,50,346,432,461,633,696],"critical":[40],"activation,":[42],"proliferation":[43],"and":[44,49,109,133,186,220,239,261,269,294,309,374,410,425,451,493,529,553,589,595,611,619,636,750],"survival":[45,499],"of":[46,61,112,142,147,152,154,217,250,279,334,371,391,470,475,500,561,579,605,608,613,623,629,643,673,681,704],"B":[47],"cells,":[48],"hyperactive":[51],"in":[52,67,80,396,440,464,485,542,550,593,598,625,640,661,713,717,739,757],"many":[53],"B-cell":[54,735],"malignancies.":[55],"Idelalisib,":[56],"a":[57,214,331,467,697],"selective":[58],"oral":[59],"inhibitor":[60,699],"PI3Kd,":[62],"demonstrated":[63],"considerable":[64],"clinical":[65,659],"activity":[66],"double-refractory":[68,114,599],"(Gopal":[70],"NEJM":[71],"2014).":[72],"FDA":[73],"granted":[74],"accelerated":[75],"approval":[76],"Idelalisib":[78,160],"(Zydelig\u00ae)":[79],"who":[82,741,759],"have":[83,568,742,760],"received":[84,743,761],"at":[85,744,762],"least":[86,745,763],"two":[87,746,764],"prior":[88,251,277,325,473,652,747,765],"systemic":[89,748,766],"relapsed":[92],"FL":[93,404,419,445,488],"or":[94,145,171],"SLL.":[95],"Based":[96,532],"on":[97,533],"these":[98,551],"encouraging":[99],"initial":[100],"results,":[101],"we":[102],"now":[103],"describe":[104],"long-term":[105],"follow":[106],"up,":[107],"safety,":[108],"remission":[110],"durations":[111],"this":[113,195,644,662],"population":[116,601,665],"treated":[117],"idelalisib.":[119],"Methods:":[120],"Eligible":[121],"pts":[123,209,274,286,296,304,311,384,392,460,544,555,566],"included":[124,221],"those":[125],"measurable":[127],"an":[134,177,585,603],"agent.":[136],"Refractory":[137],"was":[138,165,197,253,327,367,378,503,547,581,590],"defined":[139],"as":[140],"lack":[141],"response":[143,343,366,617],"to,":[144],"progression":[146,170,322],"lymphoma":[148,223,229,235,241,737,755],"within":[149],"6":[150],"months":[151,201,336,369,441,477,486],"completion":[153],"index":[155],"therapy,":[156],"confirmed":[157],"by":[158,176,675,683],"imaging.":[159],"150":[161],"mg":[162],"PO":[163],"BID":[164],"administered":[166],"continuously":[167],"until":[168],"intolerance.":[172],"Responses":[173],"were":[174,283,288,298,382,557],"evaluated":[175,639],"independent":[178],"review":[179],"committee,":[180],"using":[181],"criteria":[183],"(Cheson,":[184],"2007,":[185],"Owen":[187],"2013).":[188],"The":[189,247,318,362,479,496,506,576,616,646],"new":[190],"data":[191],"cutoff":[192],"date":[193],"analysis":[196],"June":[198],"2014,":[199],"20":[200],"after":[202],"last":[204,292,324,472],"patient":[205,664],"enrolled.":[206],"Results:":[207],"Enrolled":[208],"(N":[210],"=":[211,350],"125)":[212],"had":[213,276,306,313,584],"median":[215,248,319,332,363,430,468,480,497],"age":[216],"64":[218],"years":[219],"follicular":[222,734],"(FL)":[224,738],"n=72":[225],"(58%),":[226],"small":[227,627,753],"lymphocytic":[228,710,754],"(SLL)":[230,756],"n=28":[231],"(22%),":[232],"marginal":[233],"zone":[234],"(MZL)":[236],"n=15":[237],"(12%)":[238],"lymphoplasmacytic":[240],"(LPL)/Waldenstrom's":[242],"macroglobulinemia":[243],"(WM)":[244],"n=10":[245],"(8%).":[246],"number":[249,628],"4":[254],"[range":[255],"2-12],":[256],"including":[257],"bendamustine/rituximab":[258],"(BR)":[259],"(n=60)":[260],"rituximab,":[262,716],"cyclophosphamide,":[263],"doxorubicin,":[264],"vincristine,":[265],"prednisone":[266],"(R-CHOP)":[267],"(n=56)":[268],"autologous":[270],"transplant":[271],"(n=14).":[272],"81":[273],"(65%)":[275],"bendamustine,":[278],"which":[280],"61/81":[281],"(75%)":[282],"refractory.":[284],"112":[285],"(90%)":[287],"their":[291],"regimen,":[293],"99":[295],"(79%)":[297],"\u22652":[301],"regimens.":[302],"38":[303],"(30%)":[305],"elevated":[307],"LDH,":[308],"33":[310],"(26%)":[312],"bulky":[314],">7":[316],"cm.":[317],"time":[320,364,375],"from":[323],"therapy":[326,570,727],"3.9":[328,476],"months.":[329,380,435,505,615],"With":[330],"exposure":[333],"11.1":[335],"(range":[337],"0.7":[338],"35.4),":[340],"overall":[342,498],"rate":[344,414,618],"(ORR)":[345],"56%":[347],"(95%":[348],"CI":[349],"46.8-64.9)":[351],"70":[353],"responders,":[354,429],"comprising":[355],"12":[356],"CRs":[357],"(9.6%),":[358],"58":[359],"PRs":[360],"(46.4%).":[361],"1.9":[368],"(time":[370],"first":[372],"evaluation)":[373],"CR":[377,413],"4.5":[379],"There":[381],"43":[383],"stable":[386],"(SD)":[388],"(34.4%).":[389],"90%":[390],"experienced":[393],"some":[394],"decrease":[395],"tumor":[397],"burden.":[398],"ORR":[399,604],"subtypes":[402,417,439,484],"is:":[403,418,444],"(54%),":[405],"SLL":[406,421,447],"(61%),":[407],"MZL":[408,423,449,491],"(47%),":[409],"LPL/WM":[411,426,452,494,632],"(70%).":[412],"(14%),":[420],"(4%),":[422],"(7%),":[424],"(0%).":[427],"Among":[428],"DOR":[431,436,612],"13.9":[433,614],"(0.03-31.3)":[434],"(Figure":[442],"1)":[443,707],"11.8,":[446],"13.9,":[448],"18.4,":[450],"(not":[453],"yet":[454],"reached).":[455],"Median":[456],"PFS":[457,469,481,607],"all":[459,501],"11.0":[462],"months,":[463,610],"comparison":[465],"regimen":[474],"(p<.0001).":[478],"individual":[483],"was:":[487],"11.0,":[489],"SLL11.1,":[490],"6.6,":[492],"22.2.":[495],"30.8":[504],"adverse":[507,573],"events":[508],"include":[509],"(total%/\u2265":[510],"grade":[511],"3%)":[512],"diarrhea/colitis":[513],"(50/18),":[514],"fatigue":[515],"(30/2),":[516,522],"nausea":[517],"(31/2),":[518],"cough":[519],"(32/0),":[520],"pyrexia":[521],"dyspnea":[523],"(18/5),":[524],"rash":[525],"(14/2),":[526],"pneumonia":[527],"(14/11),":[528],"pneumonitis":[530],"(4/3).":[531],"central":[534],"laboratory":[535],"measurements,":[536],"Grade":[537],"\u22653":[538],"ALT/AST":[539,562],"elevations":[540],"occurred":[541],"18":[543],"(14%).":[545],"Drug":[546],"temporarily":[548],"held":[549],"pts,":[552],"11/15":[554],"(73%)":[556],"re-treated":[558],"without":[559],"recurrence":[560],"elevation.":[563],"Overall,":[564],"30":[565],"(24%)":[567],"discontinued":[569],"due":[571,728],"events.":[574],"Conclusions:":[575],"prolonged":[577,658],"administration":[578],"idelalisib":[580],"well":[582],"tolerated,":[583],"acceptable":[586],"safety":[587],"profile,":[588],"highly":[591],"effective":[592],"inducing":[594],"maintaining":[596],"remissions":[597],"56%,":[606],"11":[609],"long":[620],"term":[621],"duration":[622],"responses":[624],"subjects":[630],"very":[634],"promising,":[635],"will":[637],"be":[638,724],"larger":[641],"trials":[642],"disease.":[645],"observed":[647],"control":[649],"compared":[650],"regimens":[653],"suggests":[654],"potential":[656],"benefit":[660],"challenging":[663],"unmet":[667],"medical":[668],"need.":[669],"Figure":[670,678],"1:":[671],"Duration":[672,680],"Response":[674,682],"Disease":[676,684],"Group.":[677,685],"1:.":[679],"Disclosures":[686],"Gopal:":[687],"Gilead":[688],"Sciences:":[689,769,774,778,782,786,790,794,798,802,806,810,814,818,822,826,831,836,841],"Research":[690,770,775,779,783,787,791,795,799,803,807,811,815,819,823,842],"Funding.":[691,771,776,780,784,788,792,796,800,804,808,812,816,820,824,843],"Off":[692],"Label":[693],"Use:":[694],"Zydelig":[695],"kinase":[698],"indicated":[700],"treatment":[703],"with:":[706],"Relapsed":[708,733,752],"chronic":[709],"leukemia":[711],"(CLL),":[712],"combination":[714],"whom":[720],"alone":[722],"would":[723],"considered":[725],"appropriate":[726],"other":[730],"co-morbidities;":[731],"2)":[732],"non-Hodgkin":[736],"therapies;":[749],"3)":[751],"therapies..":[767],"Kahl:Gilead":[768],"de":[772],"Vos:Gilead":[773],"Wagner-Johnston:Gilead":[777],"Schuster:Gilead":[781],"Jurczak:Gilead":[785],"Flinn:Gilead":[789],"Flowers:Gilead":[793],"Martin:Gilead":[797],"Viardot:Gilead":[801],"Blum:Gilead":[805],"Goy:Gilead":[809],"Davies:Gilead":[813],"Zinzani:Gilead":[817],"Dreyling:Gilead":[821],"Holes:Gilead":[825],"Employment,":[827,832,837],"Equity":[828,833,838],"Ownership.":[829,834,839],"Sorensen:Gilead":[830],"Godfrey:Gilead":[835],"Salles:Gilead":[840]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}